Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GILD | AMGN | BMY | ||
| Company | Gilead Sciences Inc | Amgen Inc | Bristol-Myers Squibb Company | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 138.95 | 351.90 | 59.20 | ||
| High | 139.76 | 356.00 | 60.43 | ||
| Low | 136.69 | 349.42 | 58.54 | ||
| Latest | 138.02 | 355.40 | 60.33 | ||
| Change | -0.53 | +6.01 | +1.37 | ||
| % Change | -0.38% | +1.72% | +2.32% | ||
| Volume | 1,643,292 | 882,994 | 4,087,594 | ||
| 20-Day Average Volume | 5,602,124 | 2,670,753 | 12,426,221 | ||
| Previous Close | 138.55 | 349.39 | 58.96 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 138.75 | 349.82 | 58.90 | ||
| 20-Day Raw Stochastic | 44.38% | 82.28% | 64.94% | ||
| 20-Day Relative Strength | 45.47 | 50.28 | 54.24 | ||
| Weighted Alpha | +31.71 | +26.68 | +30.95 | ||
| Today's Opinion | 40% Buy | 56% Buy | 80% Buy | ||
| Previous Opinion | 40% Buy | 40% Buy | 64% Buy | ||
| Last Month's Opinion | 80% Buy | 56% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.77% since 04/10/26 | +1.17% since 04/10/26 | +2.70% since 04/10/26 | ||
| Low | 136.98 on 04/17/26 | 344.21 on 04/15/26 | 57.22 on 04/15/26 | ||
| High | 141.40 on 04/14/26 | 355.46 on 04/17/26 | 60.21 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | -4.49% since 03/17/26 | -1.66% since 03/17/26 | +0.82% since 03/17/26 | ||
| Low | 133.89 on 03/30/26 | 335.06 on 04/07/26 | 56.45 on 03/24/26 | ||
| High | 143.79 on 03/18/26 | 360.68 on 03/18/26 | 62.22 on 04/01/26 | ||
| 3-Month | |||||
| %Chg | +10.42% since 01/16/26 | +7.48% since 01/16/26 | +8.94% since 01/16/26 | ||
| Low | 122.28 on 01/20/26 | 321.71 on 01/20/26 | 53.54 on 01/21/26 | ||
| High | 157.29 on 02/11/26 | 391.29 on 03/02/26 | 62.89 on 03/02/26 | ||
| 6-Month | |||||
| %Chg | +12.30% since 10/17/25 | +18.85% since 10/17/25 | +37.98% since 10/17/25 | ||
| Low | 114.02 on 10/31/25 | 288.00 on 10/31/25 | 42.52 on 10/29/25 | ||
| High | 157.29 on 02/11/26 | 391.29 on 03/02/26 | 62.89 on 03/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 171,971,328 | 188,560,544 | 120,380,688 | ||
| Shares Outstanding, K | 1,241,222 | 539,685 | 2,041,735 | ||
| Annual Sales | 29,443,000,000 | 36,751,000,000 | 48,194,000,000 | ||
| Annual Net Income | 8,510,000,000 | 7,711,000,000 | 7,054,000,000 | ||
| Last Quarter Sales | 7,925,000,000 | 9,866,000,000 | 12,502,000,000 | ||
| Last Quarter Net Income | 2,183,000,000 | 1,333,000,000 | 1,086,000,000 | ||
| 60-Month Beta | 0.39 | 0.47 | 0.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.86 on 02/10/26 | 5.29 on 02/03/26 | 1.26 on 02/05/26 | ||
| Latest Earnings Date | 05/07/26 | 04/30/26 | 04/30/26 | ||
| Most Recent Dividend | 0.820 on 03/13/26 | 2.520 on 02/13/26 | 0.630 on 04/02/26 | ||
| Next Ex-Dividends Date | 03/13/26 | 05/15/26 | 04/02/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 17.15 | 15.94 | 9.41 | ||